Lee Lueder analyst

Currently out of the existing stock ratings of Lee Lueder, 4 are a HOLD (36.36%), 7 are a BUY (63.64%).

Lee Lueder

Work Performance Price Targets & Ratings Chart

Analyst Lee Lueder, has had 91.67% of price targets met with an average potential upside of 19.33%, reached in 150 days on average. Previously, Lee Lueder worked at DEUTSCHE BANK.

Lee Lueder has documented 23 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CRL, Charles River Laboratories at 22-Mar-2024.

Wall Street Analyst Lee Lueder

Analyst best performing recommendations are on IQV (IQVIA HOLDINGS).
The best stock recommendation documented was for CRL (CHARLES RIVER LABORATORIES) on 11/9/2023. The price target of $215 was fulfilled within 34 days with a profit of $45.53 (26.87%), with a performance score of 7.9.

Average potential price target upside

CRL Charles River Laboratories CTLT Catalent IQV IQVIA Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Jul-2025

$400

$85.68 (27.26%)

$330

17 days ago
(05-Nov-2026)

12/13 (92.31%)

$86.98 (27.79%)

150

Buy Since 06-Nov-2025

$375

$60.68 (19.31%)

$330

17 days ago
(05-Nov-2026)

14/15 (93.33%)

$61.98 (19.80%)

51

Buy Since 06-Aug-2026

$352

$37.68 (11.99%)

$322

17 days ago
(05-Nov-2026)

3/3 (100%)

$38.98 (12.45%)

12

Buy Since 28-Sep-2026

$340

$25.68 (8.17%)

$195

1 months 25 days ago
(28-Sep-2026)

34/35 (97.14%)

$45.41 (15.41%)

227

Hold Since 07-Jun-2024

$295

$-19.32 (-6.15%)

$230

1 months 28 days ago
(25-Sep-2026)

12/12 (100%)

$2.16 (0.74%)

33

Show more analysts

Stocks Lee Lueder covered previously. Scores are shown for active stocks only.

PPD PPD

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?